{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:58:00Z","timestamp":1791640680476,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Jiangsu Funding Program for Excellent Postdoctoral Talent","award":["2022ZB119"],"award-info":[{"award-number":["2022ZB119"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92059202"],"award-info":[{"award-number":["92059202"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130060"],"award-info":[{"award-number":["82130060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92359304"],"award-info":[{"award-number":["92359304"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61821002"],"award-info":[{"award-number":["61821002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372023"],"award-info":[{"award-number":["82372023"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172010"],"award-info":[{"award-number":["82172010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81830053"],"award-info":[{"award-number":["81830053"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the National Key R&D Program of China","award":["2021YFF0501504"],"award-info":[{"award-number":["2021YFF0501504"]}]},{"name":"the National Key R&D Program of China","award":["2022YFE0116700"],"award-info":[{"award-number":["2022YFE0116700"]}]},{"name":"the Natural Science Foundation of Jiangsu Province","award":["BK20220831"],"award-info":[{"award-number":["BK20220831"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["2242022R20066"],"award-info":[{"award-number":["2242022R20066"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00259-024-06952-y","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T10:02:40Z","timestamp":1729245760000},"page":"1119-1136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Enhancing the tissue penetration to improve sonodynamic immunotherapy for pancreatic ductal adenocarcinoma using membrane-camouflaged nanoplatform"],"prefix":"10.1007","volume":"52","author":[{"given":"Jiawei","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziting","family":"Que","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyan","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyanqiu","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengqin","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5041-7865","authenticated-orcid":false,"given":"Shenghong","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"issue":"1","key":"6952_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7\u201334.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"6952_CR2","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1001\/jamaoncol.2019.1588","volume":"5","author":"EM O\u2019Reilly","year":"2019","unstructured":"O\u2019Reilly EM, Oh DY, Dhani N, et al. Durvalumab with or without Tremelimumab for patients with metastatic pancreatic ductal adenocarcinoma: a phase 2 Randomized Clinical Trial. JAMA Oncol. 2019;5(10):1431\u20138.","journal-title":"JAMA Oncol"},{"issue":"8","key":"6952_CR3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","volume":"17","author":"AN Hosein","year":"2020","unstructured":"Hosein AN, Brekken RA, Maitra A. Pancreatic cancer stroma: an update on therapeutic targeting strategies. Nat Rev Gastroenterol Hepatol. 2020;17(8):487\u2013505.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"6952_CR4","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1136\/gutjnl-2021-324834","volume":"71","author":"S Kumar","year":"2022","unstructured":"Kumar S, Schoonderwoerd MJA, Kroonen JS, et al. Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model. Gut. 2022;71(11):2266\u201383.","journal-title":"Gut"},{"issue":"1","key":"6952_CR5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40169-019-0226-9","volume":"8","author":"SK Daniel","year":"2019","unstructured":"Daniel SK, Sullivan KM, Labadie KP, Pillarisetty VG. Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma. Clin Transl Med. 2019;8(1):10.","journal-title":"Clin Transl Med"},{"issue":"10","key":"6952_CR6","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41419-022-05351-1","volume":"13","author":"T Zhang","year":"2022","unstructured":"Zhang T, Ren Y, Yang P, Wang J, Zhou H. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Cell Death Dis. 2022;13(10):897.","journal-title":"Cell Death Dis"},{"issue":"9","key":"6952_CR7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","volume":"17","author":"WJ Ho","year":"2020","unstructured":"Ho WJ, Jafee EM, Zheng L. The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities. Nat Rev Clin Oncol. 2020;17(9):527\u201340.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"6952_CR8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, Zhang B, Meng Q, Yu X, Shi S. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20(1):131.","journal-title":"Mol Cancer"},{"issue":"1","key":"6952_CR9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13046-023-02935-3","volume":"43","author":"W Luo","year":"2024","unstructured":"Luo W, Wen T, Qu X. Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept. J Exp Clin Cancer Res. 2024;43(1):8.","journal-title":"J Exp Clin Cancer Res"},{"key":"6952_CR10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.actbio.2021.09.010","volume":"136","author":"L Song","year":"2021","unstructured":"Song L, Hou X, Wong KF, Yang Y, Qiu Z, Wu Y, Hou S, Fei C, Guo J, Sun L. Gas-filled protein nanostructures as cavitation nuclei for molecule-specific sonodynamic therapy. Acta Biomater. 2021;136:533\u201345.","journal-title":"Acta Biomater"},{"key":"6952_CR11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.actbio.2023.02.038","volume":"161","author":"H Xiao","year":"2023","unstructured":"Xiao H, Li X, Li B, Zhong Y, Qin J, Wang Y, Han S, Ren J, Shuai X. Sono-promoted drug penetration and extracellular matrix modulation potentiate sonodynamic therapy of pancreatic ductal adenocarcinoma. Acta Biomater. 2023;161:265\u201374.","journal-title":"Acta Biomater"},{"issue":"2","key":"6952_CR12","doi-asserted-by":"crossref","first-page":"e2204365","DOI":"10.1002\/advs.202204365","volume":"10","author":"Y Yang","year":"2023","unstructured":"Yang Y, Huang J, Liu M, et al. Emerging Sonodynamic Therapy-based nanomedicines for Cancer Immunotherapy. Adv Sci (Weinh). 2023;10(2):e2204365.","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"6952_CR13","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.immuni.2020.05.001","volume":"52","author":"J Ni","year":"2020","unstructured":"Ni J, Wang X, Stojanovic A, Zhang Q, Wincher M, B\u00fchler L, Arnold A, Correia MP, Winkler M, Koch PS, Sexl V, H\u00f6fer T, Cerwenka A. Single-cell RNA sequencing of Tumor-infiltrating NK cells reveals that inhibition of transcription factor HIF-1\u03b1 unleashes NK Cell activity. Immunity. 2020;52(6):1075\u2013e10878.","journal-title":"Immunity"},{"issue":"8","key":"6952_CR14","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1021\/acs.molpharmaceut.1c00085","volume":"18","author":"DA Murphy","year":"2021","unstructured":"Murphy DA, Cheng H, Yang T, Yan X, Adjei IM. Reversing hypoxia with PLGA-Encapsulated Manganese Dioxide nanoparticles improves natural killer cell response to Tumor spheroids. Mol Pharm. 2021;18(8):2935\u201346.","journal-title":"Mol Pharm"},{"key":"6952_CR15","doi-asserted-by":"crossref","first-page":"123466","DOI":"10.1016\/j.ijbiomac.2023.123466","volume":"233","author":"AK Shukla","year":"2023","unstructured":"Shukla AK, Randhawa S, Saini TC, Acharya A. Carbon Nanosphere based bifunctional oxidoreductase nano-catalytic agent to mitigate hypoxia in cancer cells. Int J Biol Macromol. 2023;233:123466.","journal-title":"Int J Biol Macromol"},{"issue":"11","key":"6952_CR16","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1016\/j.apsb.2020.06.004","volume":"10","author":"J Yin","year":"2020","unstructured":"Yin J, Cao H, Wang H, Sun K, Li Y, Zhang Z. Phospholipid membrane-decorated deep-penetrated nanocatalase relieve tumor hypoxia to enhance chemo-photodynamic therapy. Acta Pharm Sin B. 2020;10(11):2246\u201357.","journal-title":"Acta Pharm Sin B"},{"issue":"20","key":"6952_CR17","doi-asserted-by":"crossref","first-page":"9214","DOI":"10.1039\/D3NR01052J","volume":"15","author":"W Li","year":"2023","unstructured":"Li W, Liu S, Zhang Y, Zhou J, Li R, Gai S, Zhong L, Yang P. Dual-inhibition of lactate metabolism and prussian blue-mediated radical generation for enhanced chemodynamic therapy and antimetastatic effect. Nanoscale. 2023;15(20):9214\u201328.","journal-title":"Nanoscale"},{"key":"6952_CR18","doi-asserted-by":"crossref","first-page":"100927","DOI":"10.1016\/j.blre.2022.100927","volume":"54","author":"NB Charbe","year":"2022","unstructured":"Charbe NB, Castillo F, Tambuwala MM, et al. A new era in oxygen therapeutics? From perfluorocarbon systems to haemoglobin-based oxygen carriers. Blood Rev. 2022;54:100927.","journal-title":"Blood Rev"},{"issue":"41","key":"6952_CR19","doi-asserted-by":"crossref","first-page":"e202209610","DOI":"10.1002\/anie.202209610","volume":"61","author":"J Cen","year":"2022","unstructured":"Cen J, Ye X, Liu X, et al. Fluorinated Copolypeptide-stabilized microbubbles with Maleimide-Decorated surfaces as Long-Term Ultrasound contrast agents. Angew Chem Int Ed Engl. 2022;61(41):e202209610.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"6952_CR20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40824-022-00296-0","volume":"26","author":"X Li","year":"2022","unstructured":"Li X, Wang H, Li Z, et al. Oxygen tank for synergistic hypoxia relief to enhance mitochondria-targeted photodynamic therapy. Biomater Res. 2022;26(1):47.","journal-title":"Biomater Res"},{"issue":"48","key":"6952_CR21","doi-asserted-by":"crossref","first-page":"e2005295","DOI":"10.1002\/adma.202005295","volume":"32","author":"L Sun","year":"2020","unstructured":"Sun L, Xu Y, Zhang X, et al. Mesenchymal stem cells functionalized Sonodynamic treatment for improving therapeutic efficacy and compliance of orthotopic oral Cancer. Adv Mater. 2020;32(48):e2005295.","journal-title":"Adv Mater"},{"key":"6952_CR22","doi-asserted-by":"crossref","first-page":"119907","DOI":"10.1016\/j.biomaterials.2020.119907","volume":"241","author":"J Feng","year":"2020","unstructured":"Feng J, Xu M, Wang J, Zhou S, Liu Y, Liu S, Huang Y, Chen Y, Chen L, Song Q, Gong J, Lu H, Gao X, Chen J. Sequential delivery of nanoformulated \u03b1-mangostin and triptolide overcomes permeation obstacles and improves therapeutic effects in pancreatic cancer. Biomaterials. 2020;241:119907.","journal-title":"Biomaterials"},{"issue":"25","key":"6952_CR23","doi-asserted-by":"crossref","first-page":"e2209785","DOI":"10.1002\/adma.202209785","volume":"35","author":"X Xu","year":"2023","unstructured":"Xu X, Zhang Z, Du J, Xue Y, Chen X, Zhang J, Yang X, Chang D, Xie J, Ju S. Recruiting T-Cells toward the brain for enhanced glioblastoma immunotherapeutic efficacy by Co-delivery of cytokines and Immune Checkpoint antibodies with Macrophage-Membrane-Camouflaged Nanovesicles. Adv Mater. 2023;35(25):e2209785.","journal-title":"Adv Mater"},{"key":"6952_CR24","doi-asserted-by":"crossref","unstructured":"Zlotver I, Sosnik A. Glucosylated hybrid TiO2 \/Polymer nanomaterials for actively targeted Sonodynamic Therapy of Cancer. Small. 2023;20(4):e2305475.","DOI":"10.1002\/smll.202305475"},{"issue":"7","key":"6952_CR25","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1053\/j.gastro.2022.02.024","volume":"162","author":"CJ Garcia Garcia","year":"2022","unstructured":"Garcia Garcia CJ, Huang Y, Fuentes NR, et al. Stromal HIF2 regulates Immune suppression in the pancreatic Cancer Microenvironment. Gastroenterology. 2022;162(7):2018\u201331.","journal-title":"Gastroenterology"},{"issue":"12","key":"6952_CR26","doi-asserted-by":"crossref","first-page":"e005491","DOI":"10.1136\/jitc-2022-005491","volume":"10","author":"M Perez-Penco","year":"2022","unstructured":"Perez-Penco M, Weis-Banke SE, Schina A, et al. TGF\u03b2-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer. J Immunother Cancer. 2022;10(12):e005491.","journal-title":"J Immunother Cancer"},{"issue":"6","key":"6952_CR27","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2022.07.076","volume":"163","author":"J Datta","year":"2022","unstructured":"Datta J, Dai X, Bianchi A, et al. Combined MEK and STAT3 inhibition uncovers stromal plasticity by enriching for Cancer-Associated fibroblasts with mesenchymal stem cell-like features to overcome Immunotherapy Resistance in Pancreatic Cancer. Gastroenterology. 2022;163(6):1593\u2013612.","journal-title":"Gastroenterology"},{"key":"6952_CR28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.addr.2021.02.012","volume":"172","author":"H Liu","year":"2021","unstructured":"Liu H, Shi Y, Qian F. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts. Adv Drug Deliv Rev. 2021;172:37\u201351.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"6952_CR29","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41571-018-0007-1","volume":"15","author":"KC Valkenburg","year":"2018","unstructured":"Valkenburg KC, de Groot AE, Pienta KJ. Targeting the tumour stroma to improve cancer therapy. Nat Rev Clin Oncol. 2018;15(6):366\u201381.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"6952_CR30","first-page":"25","volume":"9","author":"GQ Zhu","year":"2023","unstructured":"Zhu GQ, Tang Z, Huang R, et al. CD36\u2009+\u2009cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor. Cell Discov. 2023;9(1):25.","journal-title":"Cell Discov"},{"issue":"12","key":"6952_CR31","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s41423-022-00930-w","volume":"19","author":"HJ Kim","year":"2022","unstructured":"Kim HJ, Yang K, Kim K, et al. Reprogramming of cancer-associated fibroblasts by apoptotic cancer cells inhibits lung metastasis via Notch1-WISP-1 signaling. Cell Mol Immunol. 2022;19(12):1373\u201391.","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"6952_CR32","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A. Pancreatic cancer: advances and challenges. Cell. 2023;186(8):1729\u201354.","journal-title":"Cell"},{"issue":"6","key":"6952_CR33","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","volume":"25","author":"AD Rhim","year":"2014","unstructured":"Rhim AD, Oberstein PE, Thomas DH, et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell. 2014;25(6):735\u201347.","journal-title":"Cancer Cell"},{"issue":"19","key":"6952_CR34","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.4155\/fmc-2021-0146","volume":"13","author":"T Chavan","year":"2021","unstructured":"Chavan T, Muth A. The diverse bioactivity of \u03b1-mangostin and its therapeutic implications. Future Med Chem. 2021;13(19):1679\u201394.","journal-title":"Future Med Chem"},{"issue":"5","key":"6952_CR35","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3390\/biomedicines10051116","volume":"10","author":"P Borzdzi\u0142owska","year":"2022","unstructured":"Borzdzi\u0142owska P, Bednarek I. The Effect of \u03b1-Mangostin and cisplatin on ovarian Cancer cells and the Microenvironment. Biomedicines. 2022;10(5):1116.","journal-title":"Biomedicines"},{"issue":"10","key":"6952_CR36","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41419-020-03133-1","volume":"11","author":"W Nie","year":"2020","unstructured":"Nie W, Zan X, Yu T, Ran M, Hong Z, He Y, Yang T, Ju Y, Gao X. Synergetic therapy of glioma mediated by a dual delivery system loading \u03b1-mangostin and doxorubicin through cell cycle arrest and apoptotic pathways. Cell Death Dis. 2020;11(10):928.","journal-title":"Cell Death Dis"},{"issue":"1","key":"6952_CR37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.canlet.2014.02.003","volume":"347","author":"J Lei","year":"2014","unstructured":"Lei J, Huo X, Duan W, Xu Q, Li R, Ma J, Li X, Han L, Li W, Sun H, Wu E, Ma Q. \u03b1-Mangostin inhibits hypoxia-driven ROS-induced PSC activation and pancreatic cancer cell invasion. Cancer Lett. 2014;347(1):129\u201338.","journal-title":"Cancer Lett"},{"key":"6952_CR38","doi-asserted-by":"crossref","first-page":"785586","DOI":"10.3389\/fphar.2021.785586","volume":"12","author":"TT Jiang","year":"2021","unstructured":"Jiang TT, Ji CF, Cheng XP, Gu SF, Wang R, Li Y, Zuo J, Han J. \u03b1-Mangostin alleviated HIF-1\u03b1-Mediated angiogenesis in rats with Adjuvant-Induced arthritis by suppressing aerobic glycolysis. Front Pharmacol. 2021;12:785586.","journal-title":"Front Pharmacol"},{"issue":"12","key":"6952_CR39","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.3390\/pharmaceutics13121993","volume":"13","author":"L Meylina","year":"2021","unstructured":"Meylina L, Muchtaridi M, Joni IM, Mohammed AFA, Wathoni N. Nanoformulations of \u03b1-Mangostin for Cancer Drug Delivery System. Pharmaceutics. 2021;13(12):1993.","journal-title":"Pharmaceutics"},{"issue":"37","key":"6952_CR40","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1002\/adma.201602012","volume":"28","author":"X Qian","year":"2016","unstructured":"Qian X, Zheng Y, Chen Y. Micro\/Nanoparticle-Augmented Sonodynamic Therapy (SDT): breaking the depth shallow of Photoactivation. Adv Mater. 2016;28(37):8097\u2013129.","journal-title":"Adv Mater"},{"issue":"10","key":"6952_CR41","doi-asserted-by":"crossref","first-page":"16934","DOI":"10.1021\/acsnano.1c08026","volume":"15","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Li B, Xie L, Sang W, Tian H, Li J, Wang G, Dai Y. Metal-Phenolic Network-Enabled Lactic Acid Consumption reverses immunosuppressive Tumor Microenvironment for Sonodynamic Therapy. ACS Nano. 2021;15(10):16934\u201345.","journal-title":"ACS Nano"},{"issue":"6","key":"6952_CR42","doi-asserted-by":"crossref","first-page":"e2104125","DOI":"10.1002\/advs.202104125","volume":"9","author":"X Wang","year":"2022","unstructured":"Wang X, Wu M, Li H, Jiang J, Zhou S, Chen W, Xie C, Zhen X, Jiang X. Enhancing penetration ability of semiconducting polymer nanoparticles for Sonodynamic Therapy of large solid tumor. Adv Sci (Weinh). 2022;9(6):e2104125.","journal-title":"Adv Sci (Weinh)"},{"key":"6952_CR43","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.actbio.2022.12.023","volume":"158","author":"W Wu","year":"2023","unstructured":"Wu W, Xu M, Qiao B, Huang T, Guo H, Zhang N, Zhou L, Li M, Tan Y, Zhang M, Xie X, Shuai X, Zhang C. Nanodroplet-enhanced sonodynamic therapy potentiates immune checkpoint blockade for systemic suppression of triple-negative breast cancer. Acta Biomater. 2023;158:547\u201359.","journal-title":"Acta Biomater"},{"issue":"1","key":"6952_CR44","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41467-021-27833-0","volume":"13","author":"Z Qi","year":"2022","unstructured":"Qi Z, Xu Z, Zhang L, Zou Y, Li J, Yan W, Li C, Liu N, Wu H. Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by intermittent anti-PI3K\u03b1\/\u03b2\/\u03b4 treatment. Nat Commun. 2022;13(1):182.","journal-title":"Nat Commun"},{"key":"6952_CR45","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.actbio.2023.04.001","volume":"164","author":"S Huang","year":"2023","unstructured":"Huang S, Ding D, Lan T, He G, Ren J, Liang R, Zhong H, Chen G, Lu X, Shuai X, Wei B. Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-\u03b2 to boost immune response against colorectal cancer and liver metastasis. Acta Biomater. 2023;164:538\u201352.","journal-title":"Acta Biomater"},{"issue":"1","key":"6952_CR46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12951-024-02297-8","volume":"22","author":"W Deng","year":"2024","unstructured":"Deng W, Shang H, Tong Y, Liu X, Huang Q, He Y, Wu J, Ba X, Chen Z, Chen Y, Tang K. The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy. J Nanobiotechnol. 2024;22(1):97.","journal-title":"J Nanobiotechnol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-06952-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-024-06952-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-06952-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T04:27:55Z","timestamp":1737520075000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-024-06952-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["6952"],"URL":"https:\/\/doi.org\/10.1007\/s00259-024-06952-y","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]},"assertion":[{"value":"19 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal testing was approved by the Laboratory Animal Management Committee of Southeast University (China).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All co-authors have ratified the manuscript and consented to its submission to your esteemed journal. No additional personal data is encompassed in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}